UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019810
Receipt number R000022844
Scientific Title The Frequency of Extrapyramidal Symptoms In Cancer Patients Who Receive Palliative Care. A Multi-Center, Observational Study.(FRESH study)
Date of disclosure of the study information 2015/11/16
Last modified on 2019/02/21 15:15:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Frequency of Extrapyramidal Symptoms In Cancer Patients Who Receive Palliative Care. A Multi-Center, Observational Study.(FRESH study)

Acronym

The Frequency of Extrapyramidal Symptoms In Cancer Patients Who Receive Palliative Care. A Multi-Center, Observational Study.(FRESH study)

Scientific Title

The Frequency of Extrapyramidal Symptoms In Cancer Patients Who Receive Palliative Care. A Multi-Center, Observational Study.(FRESH study)

Scientific Title:Acronym

The Frequency of Extrapyramidal Symptoms In Cancer Patients Who Receive Palliative Care. A Multi-Center, Observational Study.(FRESH study)

Region

Japan


Condition

Condition

Extrapyramidal Symptoms

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate the frequency of extrapyramidal symptoms In cancer patients who receive palliative care.

Basic objectives2

Others

Basic objectives -Others

The frequency of extrapyramidal symptoms

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

DIEPSS

Key secondary outcomes

LUNSERS EPS subscale, CAM, drug utilization


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients who are planned to receive intervention by palliative care teams or to be hospitalized in palliative care units
2) Cancer patients who were informed of their diagnosis
3) Patients who are aged 20 years or older

Key exclusion criteria

Not specified

Target sample size

600


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroto Ishiki

Organization

Research Hospital of the Institute of Medical Science, The University of Tokyo

Division name

Department of Palliative Medicine

Zip code


Address

4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan

TEL

03-3443-8111

Email

ishiki-tky@umin.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroto Ishiki

Organization

Research Hospital of the Institute of Medical Science, The University of Tokyo

Division name

Department of Palliative Medicine

Zip code


Address

4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan

TEL

03-3443-8111

Homepage URL


Email

ishiki-tky@umin.ac.jp


Sponsor or person

Institute

Research Hospital of the Institute of Medical Science, The University of Tokyo

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 11 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 11 Month 16 Day

Date of IRB


Anticipated trial start date

2015 Year 11 Month 16 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

- Prospective observational study
- Consecutive patients who visit the institutions and meet eligible criteria during one month after approval of institutional review board between Oct. 2015 and Sep. 2016.
- DIEPSS (Drug-induced extrapyramidal symptoms scale), LUNSERS (The Liverpool University Neuroleptic Side Effect Rating Scale), CAM (Confusion Assessment Method)


Management information

Registered date

2015 Year 11 Month 16 Day

Last modified on

2019 Year 02 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022844


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name